INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function

In conclusion, INT-767 significantly counteracts HFD-induced liver and fat alterations, restoring insulin sensitivity and prompting preadipocytes differentiation toward a metabolically healthy phenotype.

Source: Journal of Endocrinology - June 26, 2018 Category: Endocrinology Authors: Comeglio, P., Cellai, I., Mello, T., Filippi, S., Maneschi, E., Corcetto, F., Corno, C., Sarchielli, E., Morelli, A., Rapizzi, E., Bani, D., Guasti, D., Vannelli, G. B., Galli, A., Adorini, L., Maggi, M., Vignozzi, L. Tags: Research Source Type: research